HROW Q1 2018 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$9M+45.4% YoY

Gross Profit

$5M54.1% margin

Operating Income

-$2M-20.1% margin

Net Income

-$4M-39.6% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

+20.8%

Cash Flow

Operating Cash Flow

-$965,000

Free Cash Flow

-$1M

Stock-Based Comp.

$751,000

Balance Sheet

Total Assets

$21M

Total Liabilities

$21M

Stockholders' Equity

$83,000

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$6M	+45.4%
Gross Profit	$5M	$3M	+75.0%
Operating Income	-$2M	-$4M	+57.9%
Net Income	-$4M	-$5M	+29.8%

Revenue Segments

Product Sales, Net

$9M100%

License Revenue

$10,0000%